Interested in Cancer-Associated Thrombosis?

Click below to access Health Professional-only resources from LEO Pharma

SHOW MORE

Your expert cancer-associated Thrombosis Resource

Welcome to your Expert Cancer-Associated Thrombosis Resource.

Venous thromboembolism represents a major clinical challenge in oncology and is the second leading cause of death in cancer patients.

We aim to provide a stimulating suite of educational resources for healthcare professionals who wish to educate themselves further in this complex double-sided clinical relationship between malignancy and thrombosis.

Full Story
PREVALENCE
DIAGNOSIS
TREATMENT
MORE

It is estimated that up to 20% of patients with cancer experience venous thrombosis.2 There is a fivefold higher annual incidence of thrombosis among cancer patients, with about 1 in 1,000 in the general population and 1 in 200 in cancer patients.3

Prevalence of VTE in cancer patients
Prevalence of VTE in cancer patients
Annual incidence of VTE
Annual incidence of VTE
VTE occurred significantly more commonly in the cancer cohort than in the non-cancer cohort

PREVALENCE

Cancer-associated thrombosis (CAT) may present as a vast range of clinically significant thrombotic complications including deep vein thrombosis, pulmonary embolism, arterial thrombosis, nonbacterial thrombotic endocarditis, superficial thrombophlebitis, catheter-related thrombosis and hepatic venoclusive disease.

As diagnosis of the condition based on clinical grounds alone is unreliable, physicians should select an appropriate objective diagnostic test to confirm or refute their clinical impressions.

3D simulation of the effect of thrombosis within a capillary supplying blood to the brain causing an accumulation of erythrocytes and cerebral ischaemia

DIAGNOSIS

The treatment of cancer patients who develop deep venous Thrombosis (DVT) or pulmonary embolism (PE) is far more clinically challenging than treating VTE in the non-cancer population as the clinical course of cancer patients is characterised by increased rates of both recurrent thromboembolic episodes and bleeding complications

TREATMENT

Latest Research
healthawards.com

CAThrombosis.com awarded Silver Medal in 2015 ‘Digital Health Awards’ under auspices of Health Information Resource Center, the largest awards program in the US

More About Digital Health Award
Author Peter Rose

WELCOME


to CAThrombosis.com

Dr Peter Rose
Editor, Thrombus

More
Introductory Video Watch Now
Blood Clots, Cancer and You

Funded by LEO Pharma and developed in partnership with patient association Anticoagulation Europe, this educational video enables people living with cancer to become clot-aware and to recognise the signs and symptoms of CAT.

This video is available for patients to watch on anticoagulationeurope.org

You can set one or multiple reminders for this event by selecting from the four timed options below. You will be automatically emailed with an Event Reminder(s) at the intervals you have specified.

x
x

You are now leaving the CAThrombosis.com site. This link goes to a site where our Terms of Use does not apply. You are solely responsible for the interaction with this site.

unknown
Cathrombosis.com

This website is provided as an educational service for Healthcare Professionals in the UK and Ireland only. Please check one of the boxes below to confirm your status:

YES. I am a Healthcare Professional NO. I am not a Healthcare Professional
Cathrombosis.com

This website is intended to provide non-promotional, educational information to an international healthcare professional audience only.

You have indicated that you are not a healthcare professional and therefore, do not have access to this site.

Please click here to continue browsing
This website uses cookies to give you the best experience online and to provide anonymised, aggregated site usage data. You can find out what cookies we use, what they do and how you can disable them in our COOKIE POLICY. By browsing this website and closing this message, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.
Close
x
Cookie Policy

For the purpose of this Cookie Policy, our”, “us” or “we” means LEO Laboratories Limited (a company registered in the United Kingdom under number 662129) known as LEO Pharma (“LEO Pharma”), including LEO Pharma A/S, 2750 Ballerup, Denmark, CVR No. 56759514, LEO Laboratories Limited, Dublin, Ireland,  Reg. No. 16885 and any other LEO Pharma group company.

This website is owned by LEO Pharma.

When you use our website you accept that we use cookies as described below, unless you have altered the settings of your browser to not accept cookies.

For what purposes do we use cookies?

We use cookies on our website and any sub-domain to create the most secure and effective website possible for our visitors. Cookies may be used to help speed up your future activities and experience on our website. We also use cookies to compile anonymous, aggregated statistics that allow us to understand how people use our site and to help us improve the structure and content.

This Cookie Policy explains what cookies are, how we use them and what benefits they bring as well as how you can delete cookies.

What are cookies and what types of cookies do we use?

A cookie is a small text file that is sent to and stored on your computer, smartphone or other device for accessing the internet, whenever you visit a website. Cookies are useful because they allow a website to recognize a user's device and remember specific information about your session while you are connected. We use cookies on www.cathrombosis.com for a variety of reasons, such as to determine preferences, let users navigate between pages efficiently, verify the user and carry out other essential security checks.

Cookies by themselves cannot be used to discover the identity of the user, and they do not in any way damage your computer.

 

We use a Google Analytics cookie, further information can be seen here:: Google Analytics Cookie Usage

How do you avoid and delete cookies?

The browsers of most computers, smartphones and other web-enabled devices are typically set up to accept cookies. If you wish to amend your cookie preferences for this site or any other websites, you can do this through your browser settings. Your browser's 'help' function will tell you how to do this.

However, please remember that cookies are often used to enable and improve certain functions on our site. If you therefore choose to disable the cookies that we use, this may impact your experience while on www.cathrombosis.com, for example, you may not be able to visit certain areas of the site and you may not receive personalised information.

If you use different devices to view and access the site (e.g. your computer, smartphone, tablet etc.) you will need to ensure that each browser on each device is adjusted to suit your cookie preferences.

For more information on how to disable cookies, visit www.allaboutcookies.org